Jan Berger, MD, MJ, president & CEO, Health Intelligence Partners, and editor-in-chief of The American Journal of Pharmacy Benefits, says that historically medication adherence, when it pertained to PBMs, was really just about selling pills-it was an isolated, siloed issue.
Jan Berger, MD, MJ, president & CEO, Health Intelligence Partners, and editor-in-chief of The American Journal of Pharmacy Benefits, says that historically medication adherence, when it pertained to PBMs, was really just about selling pills—it was an isolated, siloed issue. However, pharmacy benefit managers (PBMs) began to recognize that clients were looking at adherence in a bigger, broader sense as they realized how adherence affected their lives, out-of-pocket costs, and workability.
Dr Berger also says that one of the newer areas PBMs are focusing on are medication adherence outcomes.
“Are people take their medications, and if they’re not, what are those barriers that need to be overcome in order to take it?" asks Dr Berger. "So like the rest of healthcare, we are going from a process-oriented world, to an outcomes-oriented world.”
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients are for them to live as long and as well as possible.
Read More
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More